Home    Back

Other: impact peptide 1.5    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
299Cystic fibrosis1

299. Cystic fibrosis    [ 1,592 clinical trials,   1,539 drugs,   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways]
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 1,592 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02750501
(ClinicalTrials.gov)		July 20, 201620/4/2016Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) StudyAbsorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study in Patients With Cystic Fibrosis Receiving Enteral FeedingCystic FibrosisDevice: RELiZORB (immobilized lipase) cartridge;Other: Impact Peptide 1.5Alcresta Therapeutics, Inc.Cystic Fibrosis FoundationCompleted4 YearsN/AAll49N/AUnited States